Q BioMed Inc (NASDAQ:QBIO) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday.

According to Zacks, “Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York. “

Q BioMed (NASDAQ:QBIO) opened at 3.20 on Wednesday. Q BioMed has a 12-month low of $1.26 and a 12-month high of $6.00. The stock has a 50 day moving average price of $3.23 and a 200 day moving average price of $3.08. The company’s market capitalization is $29.07 million.

ILLEGAL ACTIVITY WARNING: This piece was first reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2016/11/23/q-biomed-inc-qbio-raised-to-hold-at-zacks-investment-research.html.

Q BioMed Company Profile

Q BioMed, Inc, formerly ISMO Tech Solutions, Inc, is a biomedical acceleration and development company. The Company is focused on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. The Company intends to acquire multiple assets over time and across a spectrum of healthcare related products, companies and sectors.

5 Day Chart for NASDAQ:QBIO

Receive News & Stock Ratings for Q BioMed Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed Inc and related stocks with our FREE daily email newsletter.